Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.

Breast cancer (Tokyo, Japan)

Volumn 13, Issue 1, 2006, Pages 38-48

  Kuroi, Katsumasa ^a   Toi, Masakazu ^a   Tsuda, Hitoshi ^a   Kurosumi, Masafumi ^a   Akiyama, Futoshi ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MORTALITY; PATHOLOGY; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33646696653     PISSN: 13406868     EISSN: None     Source Type: Journal    
DOI: 10.2325/jbcs.13.38     Document Type: Review

References (57)